-
公开(公告)号:EP1019040A1
公开(公告)日:2000-07-19
申请号:EP98923600.5
申请日:1998-05-21
申请人: Bayer Corporation
发明人: RANGES, Gerald , SCOTT, William , BOMBARA, Michael , RAUNER, Deborah , REDMAN, Aniko , SMITH, Roger , PAULSEN, Holger , CHEN, Jinshan , GUNN, David , RENICK, Joel
CPC分类号: A61K31/433 , A61K31/341 , A61K31/381 , A61K31/40 , Y02A50/401 , Y02A50/411 , Y02A50/414 , Y02A50/473
摘要: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.
-
2.INHIBITION OF RAF KINASE USING SYMMETRICAL AND UNSYMMETRICAL SUBSTITUTED DIPHENYL UREAS 有权
标题翻译: RAF激酶的抑制使用平衡和不平衡取代脲公开(公告)号:EP1049664A1
公开(公告)日:2000-11-08
申请号:EP98963809.3
申请日:1998-12-22
申请人: Bayer Corporation
发明人: MILLER, Scott , OSTERHOUT, Martin , DUMAS, Jacques , KHIRE, Uday , LOWINGER, Timothy, Bruno , RIEDL, Bernd , SCOTT, William, J. , SMITH, Roger, A. , WOOD, Jill, E. , GUNN, David , RODRIGUEZ, Mareli , WANG, Ming
IPC分类号: C07C275/24 , C07D213/02 , C07D333/02 , A61K31/17 , A61K31/38 , A61K31/44
CPC分类号: C07D213/40 , C07C275/36 , C07D213/32 , C07D213/50 , C07D213/65 , C07D213/68 , C07D213/69 , C07D213/70 , C07D213/75 , C07D213/81 , C07D213/89 , C07D215/20 , C07D239/38 , C07D277/68 , C07D317/64 , C07D401/04 , C07D401/12 , C07D409/12
摘要: This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.
-
3.ARYL UREAS FOR THE TREATMENT OF INFLAMMATORY OR IMMUNOMODULATORY DISEASES 失效
标题翻译: 用于治疗炎性或免疫调节性疾病的芳基脲衍生物公开(公告)号:EP1019040B1
公开(公告)日:2004-09-29
申请号:EP98923600.5
申请日:1998-05-21
申请人: Bayer Corporation
发明人: RANGES, Gerald , SCOTT, William , BOMBARA, Michael , RAUNER, Deborah , REDMAN, Aniko , SMITH, Roger , PAULSEN, Holger , CHEN, Jinshan , GUNN, David , RENICK, Joel
CPC分类号: A61K31/433 , A61K31/341 , A61K31/381 , A61K31/40 , Y02A50/401 , Y02A50/411 , Y02A50/414 , Y02A50/473
摘要: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases other than cancer and proteolytic enzyme mediated diseases other than cancer, and pharmaceutical compositions for use in such therapy.
-
4.INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS 有权
标题翻译: p38激酶的抑制使用对称和不对称的二苯基公开(公告)号:EP1042305A1
公开(公告)日:2000-10-11
申请号:EP98964221.0
申请日:1998-12-22
申请人: Bayer Corporation
发明人: MILLER, Scott , OSTERHOUT, Martin , DUMAS, Jacques , KHIRE, Uday , LOWINGER, Timothy, Bruno , RIEDL, Bernd , SCOTT, William, J. , SMITH, Roger, A. , WOOD, Jill, E. , GUNN, David , HATOUM-MOKDAD, Holia , RODRIGUEZ, Mareli , SIBLEY, Robert , WANG, Ming , TURNER, Tiffany , BRENNAN, Catherine
IPC分类号: C07D273/00 , C07D275/00 , A61K31/17
CPC分类号: C07D207/27 , A61K31/17 , A61K31/40 , A61K31/403 , A61K31/4035 , A61K31/425 , A61K31/428 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4436 , A61K31/4439 , A61K31/535 , A61K31/5375 , C07C205/11 , C07C205/22 , C07C205/37 , C07C205/38 , C07C205/57 , C07C205/58 , C07C275/30 , C07C275/34 , C07C275/36 , C07C275/40 , C07C275/42 , C07C309/88 , C07C311/48 , C07C317/42 , C07D207/26 , C07D207/404 , C07D209/76 , C07D209/86 , C07D209/88 , C07D213/40 , C07D213/53 , C07D213/68 , C07D213/70 , C07D231/08 , C07D233/22 , C07D233/70 , C07D263/58 , C07D277/68 , C07D295/185 , C07D307/20 , C07D333/20 , C07D409/12 , Y02A50/411
摘要: This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.
-
-
-